The Jinling Cohort

Launched by NANJING SHIHEJIYIN TECHNOLOGY, INC. · Aug 23, 2023

Keywords

ClinConnect Summary

The Jinling Cohort is a research study aimed at improving early detection of cancer using a method called liquid biopsy, which involves analyzing blood samples. The study is looking for 15,000 people between the ages of 45 and 75 who live in Nanjing, China. This trial is currently recruiting participants who are in good health and willing to provide blood samples, complete health questionnaires, and have routine physical exams once a year for three years.

To be eligible for this study, individuals must be between 45 and 75 years old and must not have a history of cancer or certain medical conditions, such as recent infections or organ transplants. Participants can expect to contribute to important cancer research while receiving regular health check-ups. It's important to note that pregnant women and those with specific medical histories are not eligible to participate. If you're interested and meet the criteria, this could be a valuable opportunity to help advance cancer screening methods.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1、45-75 years of age; 2、Willing and able to undergo blood sample collection, health questionnaires and annual routine physical exams once a year for three consecutive years; 3、Residents in Nanjing; 4、Fully understand the study and able to provide a written informed consent
• Exclusion Criteria:
• • 1. Pregnant women;
• • 2. Individuals who have history of cancer or current diagnosis of cancer;
• • 3. Individuals who have organ transplant or prior non-autologous (allogeneic) bone marrow or stem cell transplant;
• • 4. Individulas who have blood transfusion within 30 days prior to the blood draw;
• • 5. Individuals who have an acute infection or inflammation within 14 days prior to the blood draw;
• • 6. Individuals who have taken medication with anti-tumor effects within 30 days prior to the blood draw;
• • 7. Individuals who will not be able to comply with the protocol procedures judged by researchers